Technical Analysis for FREQ - Frequency Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical FREQ trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | -16.06% | |
| 180 Bearish Setup | Bearish Swing Setup | -16.06% | |
| Multiple of Ten Bearish | Other | -16.06% | |
| Wide Bands | Range Expansion | -16.06% | |
| 20 DMA Support | Bullish | -29.25% | |
| Multiple of Ten Bullish | Other | -29.25% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Frequency Therapeutics is a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Frequency’s progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapeutics. The company’s lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss, the most common form of hearing loss. The company is also evaluating its PCA approach in additional diseases, including multiple sclerosis.
Biotechnology Medical Specialties Disease Multiple Sclerosis Occupational Safety And Health Perception Degenerative Diseases Hearing Loss Audiology Auditory System Hearing Sensorineural Hearing Loss
Biotechnology Medical Specialties Disease Multiple Sclerosis Occupational Safety And Health Perception Degenerative Diseases Hearing Loss Audiology Auditory System Hearing Sensorineural Hearing Loss
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 28.78 |
| 52 Week Low | 11.17 |
| Average Volume | 109,611 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 21.80 |
| 20-Day Moving Average | 18.75 |
| 10-Day Moving Average | 18.91 |
| Average True Range | 2.70 |
| ADX | 13.77 |
| +DI | 14.45 |
| -DI | 19.95 |
| Chandelier Exit (Long, 3 ATRs ) | 16.51 |
| Chandelier Exit (Short, 3 ATRs ) | 22.95 |
| Upper Bollinger Band | 22.15 |
| Lower Bollinger Band | 15.35 |
| Percent B (%b) | -0.06 |
| BandWidth | 36.27 |
| MACD Line | -0.88 |
| MACD Signal Line | -0.83 |
| MACD Histogram | -0.0536 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.20 | ||||
| Resistance 3 (R3) | 20.75 | 19.55 | 19.33 | ||
| Resistance 2 (R2) | 19.55 | 18.21 | 19.28 | 19.03 | |
| Resistance 1 (R1) | 17.25 | 17.39 | 16.65 | 16.70 | 18.74 |
| Pivot Point | 16.05 | 16.05 | 15.75 | 15.78 | 16.05 |
| Support 1 (S1) | 13.75 | 14.71 | 13.15 | 13.20 | 11.16 |
| Support 2 (S2) | 12.55 | 13.89 | 12.28 | 10.87 | |
| Support 3 (S3) | 10.25 | 12.55 | 10.58 | ||
| Support 4 (S4) | 9.70 |
